Crossref journal-article
Springer Science and Business Media LLC
Nature Medicine (297)
Bibliography

Ashcroft, G. S., Lei, K., Jin, W., Longenecker, G., Kulkarni, A. B., Greenwell-Wild, T., Hale-Donze, H., McGrady, G., Song, X.-Y., & Wahl, S. M. (2000). Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nature Medicine, 6(10), 1147–1153.

Authors 10
  1. Gillian S. Ashcroft (first)
  2. Kejian Lei (additional)
  3. Wenwen Jin (additional)
  4. Glenn Longenecker (additional)
  5. Ashok B. Kulkarni (additional)
  6. Teresa Greenwell-Wild (additional)
  7. Hollie Hale-Donze (additional)
  8. George McGrady (additional)
  9. Xiao-Yu Song (additional)
  10. Sharon M. Wahl (additional)
References 45 Referenced 328
  1. Seemuller, U. et al. The acid-stable proteinase inhibitor of human mucous secretions (HUSI-I, antileukoprotease). Complete amino acid sequence as revealed by protein and cDNA sequencing and structural homology to whey proteins and Red Sea turtle proteinase inhibitor. FEBS Lett. 199, 43 –48 (1986). (10.1016/0014-5793(86)81220-0) / FEBS Lett. by U Seemuller (1986)
  2. Eisenberg, S.P., Hale, K.K., Heimdal, P. & Thompson, R.C. Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. J. Biol. Chem. 265, 7976– 7981 (1990). (10.1016/S0021-9258(19)39026-X) / J. Biol. Chem. by SP Eisenberg (1990)
  3. Stetler, G., Brewer, M.T. & Thompson, R.C. Isolation and sequence of a human gene encoding a potent inhibitor of leukocyte proteases. Nucleic Acids Res. 14, 7883–7896 (1986). (10.1093/nar/14.20.7883) / Nucleic Acids Res. by G Stetler (1986)
  4. Thompson, R.C. & Ohlsson, K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc. Natl Acad. Sci. USA 83, 6692–6696 ( 1986). (10.1073/pnas.83.18.6692) / Proc. Natl Acad. Sci. USA by RC Thompson (1986)
  5. Franzke, C.W., Baici, A., Bartels, J., Christophers, E. & Wiedow, O. Antileukoprotease inhibits stratum corneum chymotryptic enzyme. Evidence for a regulative function in desquamation . J. Biol. Chem. 271, 21886– 21890 (1996). (10.1074/jbc.271.36.21886) / J. Biol. Chem. by CW Franzke (1996)
  6. Pemberton, A.D., Huntley, J.F. & Miller, H.R. Differential inhibition of mast cell chymases by secretory leukocyte protease inhibitor. Biochim. Biophys. Acta. 1379, 29–34 ( 1998). (10.1016/S0304-4165(97)00078-0) / Biochim. Biophys. Acta. by AD Pemberton (1998)
  7. McNeely, T.B. et al. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J. Clin. Invest. 96, 456–464 (1995). (10.1172/JCI118056) / J. Clin. Invest. by TB McNeely (1995)
  8. McNeely, T.B. et al. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription . Blood 90, 1141–1149 (1997). (10.1182/blood.V90.3.1141) / Blood by TB McNeely (1997)
  9. Tomee, J.F., Hiemstra, P.S., Heinzel-Wieland, R. & Kauffman, H.F. Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J. Infect. Dis. 176, 740– 747 (1997). (10.1086/514098) / J. Infect. Dis. by JF Tomee (1997)
  10. Zhang, Y., DeWitt, D.L., McNeely, T.B., Wahl, S.M. & Wahl, L.M. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. J. Clin. Invest. 99, 894–900 (1997). (10.1172/JCI119254) / J. Clin. Invest. by Y Zhang (1997)
  11. Song, X.-Y. et al. Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J. Exp. Med. 190, 535–542 ( 1999). (10.1084/jem.190.4.535) / J. Exp. Med. by X-Y Song (1999)
  12. Schiessler, H., Fink, E. & Fritz, H. Acid-stable proteinase inhibitors from human seminal plasma. Methods Enzymol. 45, 847– 859 (1976). (10.1016/S0076-6879(76)45078-4) / Methods Enzymol. by H Schiessler (1976)
  13. Hiemstra, P.S., van Wetering, S. & Stolk, J. Neutrophil serine proteinases and defensins in chronic obstructive pulmonary disease: effects on pulmonary epithelium . Eur. Respir. J. 12, 1200– 1208 (1998). (10.1183/09031936.98.12051200) / Eur. Respir. J. by PS Hiemstra (1998)
  14. Wingens, M. et al. Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes . J. Invest. Dermatol. 111, 996– 1002 (1998). (10.1046/j.1523-1747.1998.00425.x) / J. Invest. Dermatol. by M Wingens (1998)
  15. Wiedow, O., Harder, J., Bartels, J., Streit, V. & Christophers, E. Antileukoprotease in human skin: an antibiotic peptide constitutively produced by keratinocytes. Biochem. Biophys. Res. Commun. 248, 904–909 (1998). (10.1006/bbrc.1998.9069) / Biochem. Biophys. Res. Commun. by O Wiedow (1998)
  16. Jin, F.Y., Nathan, C., Radzioch, D. & Ding, A. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 88, 417–426 (1997). (10.1016/S0092-8674(00)81880-2) / Cell by FY Jin (1997)
  17. Weiss, S.J., Curnutte, J.T. & Regiani, S. Neutrophil-mediated solubilization of the subendothelial matrix: oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes. J. Immunol. 136, 636–641 (1986). (10.4049/jimmunol.136.2.636) / J. Immunol. by SJ Weiss (1986)
  18. Herrick, S. et al. Up-regulation of elastase in acute wounds of healthy aged humans and chronic venous leg ulcers are associated with matrix degradation . Lab. Invest. 77, 281– 288 (1997). / Lab. Invest. by S Herrick (1997)
  19. Grinnell, F. & Zhu, M. Identification of neutrophil elastase as the proteinase in burn wound fluid responsible for degradation of fibronectin. J. Invest. Dermatol. 103, 155–161 (1994). (10.1111/1523-1747.ep12392625) / J. Invest. Dermatol. by F Grinnell (1994)
  20. Ashcroft, G.S., Greenwell-Wild, T., Horan, M.A., Wahl, S.M. & Ferguson, M.W. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am. J. Pathol. 155, 1137–1146 (1999). (10.1016/S0002-9440(10)65217-0) / Am. J. Pathol. by GS Ashcroft (1999)
  21. McDonald, J.A. & Kelley, D.G. Degradation of fibronectin by human leukocyte elastase. J. Biol. Chem. 255, 8848–8858 (1980). (10.1016/S0021-9258(18)43580-6) / J. Biol. Chem. by JA McDonald (1980)
  22. Scuderi, P., Nez, P.A., Duerr, M.L., Wong, B.J. & Valdez, C.M. Cathepsin-G and leukocyte elastase inactivate human tumor necrosis factor and lymphotoxin. Cell Immunol. 135, 299–313 (1991). (10.1016/0008-8749(91)90275-G) / Cell Immunol. by P Scuderi (1991)
  23. Kafienah, W., Buttle, D.J., Burnett, D. & Hollander, A.P. Cleavage of type I collagen by human neutrophil elastase. Biochem. J. 330, 897–902 ( 1998). (10.1042/bj3300897) / Biochem. J. by W Kafienah (1998)
  24. Ferry, G. et al. Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Lett. 3, 111– 115 (1997). (10.1016/S0014-5793(96)01508-6) / FEBS Lett. by G Ferry (1997)
  25. Wahl, S.M. et al. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc. Natl Acad. Sci. USA 84, 5788–5792 (1987). (10.1073/pnas.84.16.5788) / Proc. Natl Acad. Sci. USA by SM Wahl (1987)
  26. Frank, S., Madlener, M. & Werner, S. Transforming growth factors β1, β2, and β3 and their receptors are differentially regulated during normal and impaired wound healing. J. Biol. Chem. 271, 10188 –10193 (1996). (10.1074/jbc.271.17.10188) / J. Biol. Chem. by S Frank (1996)
  27. Lentsch, A.B. et al. Inhibition of NF-κB activation and augmentation of IκBβ by secretory leukocyte protease inhibitor during lung inflammation. Am. J. Pathol. 154, 239–247 (1999). (10.1016/S0002-9440(10)65270-4) / Am. J. Pathol. by AB Lentsch (1999)
  28. Shah, M., Foreman, D.M. & Ferguson, M.W. Neutralisation of TGF-β 1 and TGF-β 2 or exogenous addition of TGF-β 3 to cutaneous rat wounds reduces scarring . J. Cell Sci. 108, 985– 1002 (1995). (10.1242/jcs.108.3.985) / J. Cell Sci. by M Shah (1995)
  29. Ashcroft, G.S. et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels. Nature Med. 3, 1209–1215 (1997). (10.1038/nm1197-1209) / Nature Med. by GS Ashcroft (1997)
  30. Ashcroft, G.S. Bidirectional regulation of macrophage function by TGF-β. Microbes Infect. 1, 1275–1282 (1999). (10.1016/S1286-4579(99)00257-9) / Microbes Infect. by GS Ashcroft (1999)
  31. Barcellos-Hoff, M.H., Derynck, R., Tsang, M.L. & Weatherbee, J.A. Transforming growth factor-β activation in irradiated murine mammary gland. J. Clin. Invest. 93, 892– 899 (1994). (10.1172/JCI117045) / J. Clin. Invest. by MH Barcellos-Hoff (1994)
  32. Nunes, I., Shapiro, R.L. & Rifkin, D.B. Characterization of latent TGF-β activation by murine peritoneal macrophages. J. Immunol. 155, 1450–1459 (1995). (10.4049/jimmunol.155.3.1450) / J. Immunol. by I Nunes (1995)
  33. Raghunath, M. et al. The cutaneous microfibrillar apparatus contains latent transforming growth factor-β binding protein-1 (LTBP-1) and is a repository for latent TGF-β1. J. Invest. Dermatol. 111, 559 –564 (1998). (10.1046/j.1523-1747.1998.00339.x) / J. Invest. Dermatol. by M Raghunath (1998)
  34. Taipale, J., Lohi, J., Saarinen, J., Kovanen, P.T. & Keski-Oja, J. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-β 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J. Biol. Chem. 270, 4689–4696 ( 1995). (10.1074/jbc.270.9.4689) / J. Biol. Chem. by J Taipale (1995)
  35. Heine, U.I. et al. Transforming growth factor-beta 1 specifically localizes in elastin during synovial inflammation: an immunoelectron microscopic study . Arch. Geschwulstforsch. 60, 289– 294 (1990). / Arch. Geschwulstforsch. by UI Heine (1990)
  36. Odekon, L.E., Blasi, F. & Rifkin, D.B. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-β to TGF-β. J. Cell Physiol. 158, 398–407 ( 1994). (10.1002/jcp.1041580303) / J. Cell Physiol. by LE Odekon (1994)
  37. Sankar, G., May, M.J. & Kopp, E.B. NK-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 161, 6297–6304 (1998). / Annu. Rev. Immunol. by G Sankar (1998)
  38. Ashcroft, G.S. et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nature Cell Biol. 1, 260–266 (1999). (10.1038/12971) / Nature Cell Biol. by GS Ashcroft (1999)
  39. Karonen, T., Jeskanen, L. & Keski-Oja, J. Transforming growth factor β 1 and its latent form binding protein-1 associate with elastic fibres in human dermis: accumulation in actinic damage and absence in anetoderma. Br. J. Dermatol. 137, 51–58 (1997). (10.1111/j.1365-2133.1997.tb03700.x) / Br. J. Dermatol. by T Karonen (1997)
  40. Grosso, L.E. & Scott, M.P. GAIPG, a repeated hexapeptide of bovine and human tropoelastin, is chemotactic for neutrophils and Lewis lung carcinoma cells. Arch. Biochem. Biophys. 305, 401–404 (1993). (10.1006/abbi.1993.1438) / Arch. Biochem. Biophys. by LE Grosso (1993)
  41. Cergneux, M., Andersen, E. & Cimasoni, G. In vitro breakdown of gingival tissue by elastase from human polymorphonuclear leukocytes. An electron microscopic study. J. Periodontal Res. 17, 169–182 (1982). (10.1111/j.1600-0765.1982.tb01142.x) / J. Periodontal Res. by M Cergneux (1982)
  42. Wahl, S.M. Transforming growth factor β: the good, the bad, and the ugly. J. Exp. Med. 180, 1587–1590 (1994). (10.1084/jem.180.5.1587) / J. Exp. Med. by SM Wahl (1994)
  43. Bosch, J.J., Zuyderhoudt, K.S., Houtkooper, F.M. & van Gool J. Histophotometric estimation of volume density of collagen as an indication of fibrosis in rat liver. Histochemistry 85, 129–133 (1986). (10.1007/BF00491759) / Histochemistry by JJ Bosch (1986)
  44. Barcellos-Hoff, M.H. et al. Immunohistochemical detection of active transforming growth factor-β in situ using engineered tissue. Am. J. Pathol. 147, 1228–1237 (1995). / Am. J. Pathol. by MH Barcellos-Hoff (1995)
  45. Chen, W., Jin, W., Cook, M., Weiner, H.L. & Wahl, S.M. Oral delivery of group A streptococcal cell wall augments circulating TGF-β and suppresses streptococcal cell wall arthritis. J. Immunol. 161, 6297– 6304 (1998). (10.4049/jimmunol.161.11.6297) / J. Immunol. by W Chen (1998)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 4:34 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 7:36 p.m.)
Indexed 2 weeks ago (Aug. 22, 2025, 12:45 a.m.)
Issued 24 years, 11 months ago (Oct. 1, 2000)
Published 24 years, 11 months ago (Oct. 1, 2000)
Published Print 24 years, 11 months ago (Oct. 1, 2000)
Funders 0

None

@article{Ashcroft_2000, title={Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing}, volume={6}, ISSN={1546-170X}, url={http://dx.doi.org/10.1038/80489}, DOI={10.1038/80489}, number={10}, journal={Nature Medicine}, publisher={Springer Science and Business Media LLC}, author={Ashcroft, Gillian S. and Lei, Kejian and Jin, Wenwen and Longenecker, Glenn and Kulkarni, Ashok B. and Greenwell-Wild, Teresa and Hale-Donze, Hollie and McGrady, George and Song, Xiao-Yu and Wahl, Sharon M.}, year={2000}, month=oct, pages={1147–1153} }